In a cancer genetic clinic-based setting, BRCA1 and BRCA2 mutation carriers have a cumulative BC risk of 71% and 64% at 70 years old, while this is 65% and 45% at 70 years in a cohort unselected for family history [15,16]. This evidence concerns the gene BRCA2 and breast cancer.